Eshe Nelson is a Reporter at The New York Times. With over a decade of experience, she specializes in business and economics, covering European economics, financial markets, and the impacts of government policies, including energy and public policy. Eshe's work has been featured in prominent publications such as The Boston Globe, The Seattle Times, and The Globe and Mail.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Eshe Nelson's coverage predominantly revolves around the global economy, central banks, and financial developments with a keen focus on data-backed analysis and government announcements. To effectively reach out to her, consider providing insights or expert commentary related to economic trends, central bank policies, inflation dynamics, or financial market analyses.
Given the substantial emphasis on citing data in her articles, offering thorough research findings or statistical analysis pertaining to economic indicators could be particularly compelling for Eshe. Additionally, pitches addressing UK and European economic landscapes are likely to align well with her areas of interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Bond yields are also higher on concerns about inflation.
JUST before Britain's fateful referendum on membership of the European Union 10 years ago, the government issued a stark warning: a vote to leave the bloc would lead to "an immediate and profound shock" to the economy.
Government borrowing costs are hitting multi-decade highs around the world, reflecting anxiety about debt levels, deficits and inflation.
By: Maggie Haberman, Victor Mather, Pranav Baskar, Jim Tankersley, Eshe Nelson, Phuriphat Dejsuphong, Jenny Gross, Alan Rappeport, David Pierson, Richard C. Paddock, Greg Jaffe, Chris Cameron, Helene Cooper
Trump Live Updates: Bessent Hosts G20 Summit; U.S. Strikes Iran for Second Time in Three Days
A global sell-off in government bonds has intensified, pushing up borrowing costs in some of the world's largest economies to their highest in decades.
LONDON — A global sell-off in government bonds intensified Tuesday, pushing up borrowing costs in some of the world’s largest economies to their highest in decades.
Just a few years ago, Novo Nordisk was the darling of the healthcare industry. Now it is teetering.
For Novo Nordisk, the Danish drugmaker behind Ozempic and Wegovy, the release of its weight-loss pill has been a much-needed triumph.
By: Elizabeth A. Harris, Lydia DePillis, Tony Romm, Colby Smith, Ben Casselman, Sydney Ember, Aruni Soni, Talmon Joseph Smith, Eshe Nelson, Ana Swanson, Gregory Schmidt
Employers added 162,000 jobs in August, and the unemployment rate held steady at 4.1 percent. But wage growth is not keeping up with rising inflation.
For Novo Nordisk, the Danish drugmaker behind Ozempic and Wegovy, the release of its weight-loss pill has been a much-needed triumph
